NeuroSense Therapeutics Ltd. Reserve Of Equity Component Of Convertible Instruments
NeuroSense Therapeutics Ltd. (NRSN) had Reserve Of Equity Component Of Convertible Instruments of $7.44 million as of 2021-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:ReserveOfEquityComponentOfConvertibleInstruments · last filed 2024-04-04
- 2021-12-31: Reserve Of Equity Component Of Convertible Instruments $7.44M.
| Period end | Reserve Of Equity Component Of Convertible Instruments |
|---|---|
| 2021-12-31 | $7.44M 20-F · filed 2024-04-04 |